Nephrocare Health Services to Hold Board Meeting for Q1 Financial Results
Nephrocare Health Services Ltd, which was previously Nephrocare Health Services Private Limited, has scheduled a meeting of its Board of Directors. The board meeting is set for Tuesday, August 11, 2026.
The purpose of the meeting is to consider and approve the Unaudited Standalone and Consolidated Financial Results of the company for the quarter that ended June 30, 2026. This event follows a previous intimation provided on June 19, 2026.
In connection with this corporate activity, the trading window for the securities of Nephrocare Health Services Ltd has been closed. The restriction applies to all Designated Persons and their immediate relatives, and the trading suspension will remain in effect from June 22, 2026, through August 13, 2026.
NEPHROPLUS Stock Price Movement
As of 12:20 PM, shares of Nephrocare Health Services Limited are slipping by 0.36% in live trading, currently valued at ₹675.45 after shedding ₹2.45 per share. The stock has seen 47,959 shares traded so far in the market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.